Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
Category: Clinical Trials
-
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
The New York Times – Business: -
‘Intrinsic Capacity’: The Most Important Longevity Term You’ve Never Heard Of
The New York Times – On the Runway:Intrinsic capacity is quickly becoming a preferred way to measure and assess human aging.
-
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
The New York Times – Business:Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
-
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
The New York Times – Business:In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
-
Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning
The New York Times – Business:In a notice flagging a series of problems with a clinical trial, the journal Nature Medicine said its editors “no longer have confidence in the integrity of the results.”
-
How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
The New York Times – Business:The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.
-
American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.
The New York Times – Business:A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.
-
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
The New York Times – Business:Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.
-
New Gene Therapy Enables Children With a Rare Form of Deafness to Hear
The New York Times – Business:The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.
-
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
The New York Times – Business:In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.
-
A Cancer Detection Test Fails in Major Study
The New York Times – Business:A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.
